If you are interested in drug discovery and want to know more about all the approved small molecule kinase inhibitors, their medical indication, pharmacology and original synthesis, check out our last perspective! @ACSBioMed@EdinUni_IGC@BOOMchemistry
https://t.co/mDDZCkdoha
Interested in using degron tagging to study the function of your favourite protein in genetically engineered mouse models? Check out our review covering recent work in this area: https://t.co/9DKLmjaH5h
🌞Delighted to see our work with @VSmerBarreto@jucaacoco@BOOMchemistry and the Carragher lab on featured in the press today!
https://t.co/XEnDNl90hK
https://t.co/smjTAM2Crh
See our last work here: https://t.co/yaIbhHObAs
After years of research, we show "Pd-triggered local chemotherapy" works in vivo and can solve inherent DMPK issues of a chemotherapy drug such as 5FU @ACSBioMed@EdinCRC@EdinUni_IGC @CRUK_BI
Interested to learn more on how molecular organisation, handedness and configuration can aid in synthetic biomaterial design? Check out our recent review here ➡️ https://t.co/MVaViiW8AY @ChemSocRev @rcontmont, Amanda Ellis, @PalliThordarson and @jonathan_steed
For those interested in #bioorthogonal catalysis, check out this new application just published in @angew_chem in collaboration with @BeckerLabCRTD https://t.co/4UtlJzFOtU
Interested in the chemistry behind approved kinase inhibitors? Check out the comprehensive perspective in Journal of Medicinal Chemistry by @BOOMchemistry here:
https://t.co/xl5hhaKgvJ
Nuvectis Pharma has licensed rights to develop and commercialize a novel, SRC/YES1 inhibitor discovered at the CRUK Edinburgh Centre @EdinCRC of the University of Edinburgh’s Institute of Genetics and Cancer @EdinUni_IGC. Read more on Yahoo! Finance 👇:
https://t.co/8mStXJuImD
10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @EdinCRC, @MRC_CRH and @CIB_CSIC!! https://t.co/Ih9SrFi44w
Check out our synthetic strategy to diversify purine libraries for drug discovery. Online on @ChemRxiv
https://t.co/dVcucjj1yc @BOOMchemistry@jjdmochon